The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling

被引:2
|
作者
Saito, Tsuyoshi [1 ]
机构
[1] Juntendo Univ, Dept Human Pathol, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan
关键词
Synovial sarcoma; chromosomal translocation t(X; 18)(p11.2; q11.2); epithelial differentiation; E-cadherin; SYT-SSX1; SYT-SSX2; E-CADHERIN EXPRESSION; TRANSCRIPTION FACTOR SNAIL; CYCLIN D1 EXPRESSION; REPRESSES E-CADHERIN; BETA-CATENIN; GENE-EXPRESSION; MESENCHYMAL TRANSITIONS; SLUG; CELLS; TRANSLOCATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Synovial sarcoma (SS) tumor cells, which have the chromosomal translocation t(X;18)(p11.2;q11.2), have an inherently greater propensity for epithelial differentiation than other mesenchymal tumors, especially spindle cell sarcomas. This is caused by de-repression of the transcription of E-cadherin by SYT-SSX1 and SYT-SSX2, which dissociate Snail or Slug, respectively, from the E-cadherin promoter. However, a subset of SS with SYT-SSX1 loses E-cadherin expression despite adequate de-repression because of mutations in E-cadherin, resulting in monophasic histology. The ratio of the expression levels of SYT-SSX1 and Snail is also associated with E-cadherin expression: the lower the SYT-SSX1/Snail ratio, the lower the level of E-cadherin expression, and vice versa, thus affecting tumor histology. In addition, Wnt signal activation caused by mutation of beta-catenin, APC, or Axin 1 and 2 is associated with monophasic histology. Remodeling of the extracellular matrix is also important. Only cells that survive all of these steps can finally exhibit biphasic histology. On the other hand, the SYT-SSX2 fusion has a weaker de-repression effect on the E-cadherin promoter than does SYT-SSX1, so it is difficult for SYT-SSX2-expressing tumors to achieve sufficient capacity for epithelial differentiation to form glandular structures. This review provides an interesting model for this epithelial differentiation that shows a possible mechanism for the aberrant mesenchymal to epithelial transition of SS and suggests that it might better be considered an epithelial to mesenchymal transition.
引用
收藏
页码:2272 / 2279
页数:8
相关论文
共 50 条
  • [41] PRIMARY SYNOVIAL SARCOMA OF THE LUNG: A CASE REPORT CONFIRMED BY MOLECULAR DETECTION OF SYT-SSX FUSION GENE TRANSCRIPTS
    Payandeh, M.
    [J]. LUNG CANCER, 2011, 71 : S27 - S28
  • [42] A phase I clinical trial of SYT-SSX fusion gene-derived peptide to patients with synovial sarcoma
    Sato, Y
    Kawaguchi, S
    Nabeta, Y
    Tsukahara, T
    Ida, K
    Nagoya, S
    Wada, T
    Yamashita, T
    Ikeda, H
    Torigoe, T
    Sato, N
    [J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S14 - S14
  • [43] Primary synovial sarcoma of the lung:: a case report confirmed by molecular detection of SYT-SSX fusion gene transcripts
    Terasaki, H
    Niki, T
    Hasegawa, T
    Yamada, T
    Suzuki, K
    Kusumoto, M
    Fujimoto, K
    Hayabuchi, N
    Matsuno, Y
    Shimoda, T
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (05) : 212 - 216
  • [44] Primary cervical tracheal monophasic synovial sarcoma confirmed by SYT-SSX gene rearrangement
    Corrales, C. E.
    Berry, G.
    Damrose, E. J.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2011, 125 (06): : 651 - 654
  • [45] Novel fluorescent ligase detection assay to identify SYT-SSX fusions in synovial sarcoma
    Gaffney, R
    Chakerian, A
    O'Connell, J
    Mathers, J
    Joste, N
    Viswanatha, D
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 337A - 338A
  • [46] Editorial Expression of Concern: Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene
    Yuntao Xie
    Maria Törnkvist
    Yan Aalto
    Gunnar Nilsson
    Leonard Girnita
    Bálint Nagy
    Sakari Knuutila
    Olle Larsson
    [J]. Oncogene, 2023, 42 : 783 - 783
  • [47] Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene (Publication with Expression of Concern)
    Xie, YT
    Törnkvist, M
    Aalto, Y
    Nilsson, G
    Girnita, L
    Nagy, B
    Knuutila, S
    Larsson, O
    [J]. ONCOGENE, 2003, 22 (48) : 7628 - 7631
  • [48] Novel fluorescent ligase detection assay to identify SYT-SSX fusions in synovial sarcoma
    Gaffney, R
    Chakerian, A
    O'Connell, J
    Mathers, J
    Joste, N
    Viswanatha, D
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 337A - 338A
  • [49] The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials
    Stegmaier, Sabine
    Leuschner, Ivo
    Poremba, Christopher
    Ladenstein, Ruth
    Kazanowska, Bernarda
    Ljungman, Gustaf
    Scheer, Monika
    Blank, Bernd
    Bielack, Stefan
    Klingebiel, Thomas
    Koscielniak, Ewa
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (01) : 89 - 95
  • [50] Primary synovial sarcoma of the lung: report of two cases confirmed by molecular detection of SYT-SSX fusion gene transcripts
    Hisaoka, M
    Hashimoto, H
    Iwamasa, T
    Ishikawa, K
    Aoki, T
    [J]. HISTOPATHOLOGY, 1999, 34 (03) : 205 - 210